Published in Eur J Paediatr Neurol on January 25, 2007
Ataluren treatment of patients with nonsense mutation dystrophinopathy. Muscle Nerve (2014) 1.41
Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology (2016) 1.41
Genetic linkage localizes an adolescent idiopathic scoliosis and pectus excavatum gene to chromosome 18 q. Spine (Phila Pa 1976) (2009) 1.01
Assessment and management of respiratory function in patients with Duchenne muscular dystrophy: current and emerging options. Ther Clin Risk Manag (2015) 0.91
Current and emerging treatment strategies for Duchenne muscular dystrophy. Neuropsychiatr Dis Treat (2016) 0.83
Duchenne muscular dystrophy: the management of scoliosis. J Spine Surg (2016) 0.75
Insights into bone health in Duchenne muscular dystrophy. Bonekey Rep (2012) 0.75
Corticosteroid Treatment Impact on Spinal Deformity in Duchenne Muscular Dystrophy. Int Sch Res Notices (2014) 0.75
Sibling concordance for clinical features of Duchenne and Becker muscular dystrophies. Muscle Nerve (2014) 0.75
Non-invasive positive pressure ventilation to facilitate the post-operative respiratory outcome of spine surgery in neuromuscular children. Eur Spine J (2014) 0.75
Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med (1999) 5.61
Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet (1999) 5.04
POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome. J Med Genet (2005) 2.80
Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. Am J Hum Genet (2001) 2.66
Mutations in the tail domain of DYNC1H1 cause dominant spinal muscular atrophy. Neurology (2012) 2.56
Impact of nasal ventilation on survival in hypercapnic Duchenne muscular dystrophy. Thorax (1998) 2.50
Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet (2001) 2.45
Prostaglandin E2 vaginal gel or tablets for the induction of labour at term: a randomised controlled trial. BJOG (2011) 2.33
Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study. Neurology (2009) 2.33
Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. Circulation (2000) 2.32
Mutations in the nebulin gene associated with autosomal recessive nemaline myopathy. Proc Natl Acad Sci U S A (1999) 2.27
A simple oral antimicrobial regimen effective in severe chronic bronchial suppuration associated with culturable Haemophilus influenzae. J Antimicrob Chemother (1983) 2.25
Color M-mode Doppler flow propagation velocity is a preload insensitive index of left ventricular relaxation: animal and human validation. J Am Coll Cardiol (2000) 2.13
Reliability of the North Star Ambulatory Assessment in a multicentric setting. Neuromuscul Disord (2009) 2.13
107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, the Netherlands. Neuromuscul Disord (2003) 2.12
Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area. Brain Res (1985) 2.11
Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy. Neurology (2006) 2.11
Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study. Neurology (2011) 2.06
Mutations in the skeletal muscle alpha-actin gene in patients with actin myopathy and nemaline myopathy. Nat Genet (1999) 2.04
Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1. Nat Genet (2001) 2.00
Management of pneumothorax in adults with cystic fibrosis. Thorax (1982) 1.99
Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene. Ann Neurol (2000) 1.84
Charcot-Marie-Tooth disease type 2 associated with mutation of the myelin protein zero gene. Neurology (1998) 1.76
RYR1 mutations are a common cause of congenital myopathies with central nuclei. Ann Neurol (2010) 1.75
Optimality score for the neurologic examination of the infant at 12 and 18 months of age. J Pediatr (1999) 1.72
Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. Heart Muscle Disease Study Group. J Am Coll Cardiol (1999) 1.71
The phenotype of limb-girdle muscular dystrophy type 2I. Neurology (2003) 1.70
Combined spinal epidural (CSE) analgesia: technique, management, and outcome of 300 mothers. Int J Obstet Anesth (1994) 1.66
Cyclosporine A treatment for Ullrich congenital muscular dystrophy: a cellular study of mitochondrial dysfunction and its rescue. Brain (2008) 1.65
Hereditary demyelinating neuropathy of infancy. A genetically complex syndrome. Brain (1997) 1.65
Comparative analysis of antisense oligonucleotide sequences for targeted skipping of exon 51 during dystrophin pre-mRNA splicing in human muscle. Hum Gene Ther (2007) 1.63
Abnormal magnetic resonance signal in the internal capsule predicts poor neurodevelopmental outcome in infants with hypoxic-ischemic encephalopathy. Pediatrics (1998) 1.59
Mutations in the FKRP gene can cause muscle-eye-brain disease and Walker-Warburg syndrome. J Med Genet (2004) 1.56
Mutations in SEPN1 cause congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome. Nat Genet (2001) 1.56
Muscle histology vs MRI in Duchenne muscular dystrophy. Neurology (2011) 1.53
Combined use of electroencephalogram and magnetic resonance imaging in full-term neonates with acute encephalopathy. Pediatrics (2001) 1.53
Visual function in infants with non-syndromic craniosynostosis. Dev Med Child Neurol (2007) 1.52
Combinations of specific DRB1, DQA1, DQB1 haplotypes are associated with insulin-dependent diabetes mellitus in Sardinia. Hum Immunol (1993) 1.52
HLA-DQA1 and -DQB1 associations with multiple sclerosis in Sardinia and French Canada: evidence for immunogenetically distinct patient groups. Neurology (1993) 1.52
Increased augmentation index in patients with cystic fibrosis. Eur Respir J (2009) 1.51
Management of scoliosis in Duchenne muscular dystrophy: a large 10-year retrospective study. Dev Med Child Neurol (2006) 1.51
Prognostic role of sentinel node biopsy in patients with thick melanoma: a meta-analysis. J Eur Acad Dermatol Venereol (2011) 1.47
Chemotherapy of advanced breast cancer: outcome and prognostic factors. Br J Cancer (1993) 1.45
Combined spinal epidural analgesia with ability to walk throughout labour. Lancet (1993) 1.45
Waterborne outbreak of Escherichia coli O157. Lancet (1991) 1.45
Adriamycin alone or combined with vincristine in the treatment of advanced breast cancer. Eur J Cancer Clin Oncol (1983) 1.42
Preserved merosin M-chain (or laminin-alpha 2) expression in skeletal muscle distinguishes Walker-Warburg syndrome from Fukuyama muscular dystrophy and merosin-deficient congenital muscular dystrophy. Neuropediatrics (1995) 1.41
Severe childhood SMA and axonal CMT due to anticodon binding domain mutations in the GARS gene. Neurology (2006) 1.39
Update on the management of Duchenne muscular dystrophy. Arch Dis Child (2008) 1.37
Immunohistological intensity measurements as a tool to assess sarcolemma-associated protein expression. Neuropathol Appl Neurobiol (2009) 1.36
Occupational asthma in a research centre breeding locusts. Clin Allergy (1980) 1.36
Lung mucociliary clearance in patients wit Young's syndrome. Chest (1981) 1.35
Obstructive azoospermia: respiratory function tests, electron microscopy and the results of surgery. Br J Urol (1978) 1.35
Controlled trial of adjuvant chemotherapy with melphalan for breast cancer. Lancet (1983) 1.35
Report on the 124th ENMC International Workshop. Treatment of Duchenne muscular dystrophy; defining the gold standards of management in the use of corticosteroids. 2-4 April 2004, Naarden, The Netherlands. Neuromuscul Disord (2004) 1.31
Automated genomic sequence analysis of the three collagen VI genes: applications to Ullrich congenital muscular dystrophy and Bethlem myopathy. J Med Genet (2005) 1.31
Social interactions of young abused children: approach, avoidance, and aggression. Child Dev (1979) 1.30
The relationship between lean body mass and bone mineral content in paediatric health and disease. Bone (2004) 1.30
Occupational asthma in a factory making flux-cored solder containing colophony. Thorax (1981) 1.29
Spontaneous migration of totally implanted venous catheter systems from subclavian into jugular veins. Thorax (1994) 1.27
A comparative analysis of collagen VI production in muscle, skin and fibroblasts from 14 Ullrich congenital muscular dystrophy patients with dominant and recessive COL6A mutations. Neuromuscul Disord (2006) 1.26
Congenital muscular dystrophy: molecular and cellular aspects. Cell Mol Life Sci (2005) 1.26
Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: association with central core disease and alteration of calcium homeostasis. Hum Mol Genet (2001) 1.25
168th ENMC International Workshop: outcome measures and clinical trials in Charcot-Marie-Tooth disease (CMT). Neuromuscul Disord (2010) 1.23
Disease severity in dominant Emery Dreifuss is increased by mutations in both emerin and desmin proteins. Brain (2006) 1.23
Congenital myasthenic syndromes in childhood: diagnostic and management challenges. J Neuroimmunol (2008) 1.22
A point mutation in the 5' splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy. Hum Mol Genet (1996) 1.21
Autosomal recessive Bethlem myopathy. Neurology (2009) 1.21
Neurological and perceptual-motor outcome at 5 - 6 years of age in children with neonatal encephalopathy: relationship with neonatal brain MRI. Neuropediatrics (2002) 1.19
Prednisolone improves the response to primary endocrine treatment for advanced breast cancer. Br J Cancer (1988) 1.19
Exon skipping mutations in collagen VI are common and are predictive for severity and inheritance. Hum Mutat (2008) 1.18
Fibreoptic bronchoscopy and diagnosis of pulmonary lesions in lymphoma and leukaemia. Thorax (1980) 1.18
Congenital myopathies--clinical features and frequency of individual subtypes diagnosed over a 5-year period in the United Kingdom. Neuromuscul Disord (2013) 1.17
Sardinian multiple sclerosis is associated with HLA-DR4: a serologic and molecular analysis. Neurology (1988) 1.17
Absence of neuronal nitric oxide synthase (nNOS) as a pathological marker for the diagnosis of Becker muscular dystrophy with rod domain deletions. Neuropathol Appl Neurobiol (2004) 1.16
Antibodies mediating type I skin test reactions to polysaccharide and protein antigens of Candida albicans. Clin Allergy (1976) 1.15
Incidental findings in healthy control research subjects using whole-body MRI. Eur J Radiol (2008) 1.14
Autosomal recessive inheritance of RYR1 mutations in a congenital myopathy with cores. Neurology (2002) 1.14
Disorganized infant, child, and adult attachment: collapse in behavioral and attentional strategies. J Am Psychoanal Assoc (2000) 1.14
An analysis of the first 300 fibreoptic bronchoscopies at the Brompton Hospital. Br J Dis Chest (1979) 1.11